Legal Opinion
Astra USA, Inc. v. Santa Clara County
Supreme Court of the United States
Decided March 29, 2011No. 09-1273PublishedCited by 185 opinions
1Opinion of the CourtJustice Ginsburg
Section 340B of the Public Health Services Act, 42 U. S. C. §256b (2006 ed. and Supp. IV), imposes ceilings on prices drug manufacturers may charge for medications sold to specified health-care facilities. Those facilities, here called “340B” or “covered” entities, include public hospitals and community health centers, many of them providers of safety-net services to the poor. The §340B ceiling-price program (340B Program) is superintended by the Health Resources and Services Administration (HRSA), a unit of the Department of Health and Human Services (HHS). Drug manufacturers opt into the…
2Cases cited9 opinions
- Alexander v. SandovalSupreme Court of the United States · 2001
- Stoneridge Investment Partners, LLC v. Scientific-Atlanta, Inc.Supreme Court of the United States · 2008
- Virginia Bankshares, Inc. v. SandbergSupreme Court of the United States · 1991
- Tenet v. DoeSupreme Court of the United States · 2005
- Audrey Price v. Samuel PierceCourt of Appeals for the Seventh Circuit · 1987
4 more not listed; retrieve them via the Exa API.
3Cited by185 opinions
- Wigod v. Wells Fargo Bank, N.A.Court of Appeals for the Seventh Circuit · 2012
- Armstrong v. Exceptional Child Center, Inc.Supreme Court of the United States · 2015
- United States Ex Rel. Schumann v. Astrazeneca Pharmaceuticals L.P.Court of Appeals for the Third Circuit · 2014
- Goss v. Bank of America, N.A.District Court, D. Maryland · 2013
- Douglas v. Independent Living Center of Southern California, Inc.Supreme Court of the United States · 2012
180 more not listed; retrieve them via the Exa API.